Literature DB >> 1360911

Regulation of growth hormone secretion.

L A Frohman1, T R Downs, P Chomczynski.   

Abstract

The secretion of growth hormone (GH) is controlled by a complex regulatory system. The primary control is exerted by two neuroendocrine hormones, GH-releasing hormone and somatostatin, though other hypothalamic neuropeptides directly and indirectly participate in this process. The regulation of each of these neurohormones is now being clarified at both physiologic and molecular levels, as are their respective roles in the generation of pulsatile GH secretion and in GH feedback regulation. Considerable information has been amassed concerning signal transduction systems mediating the effects of hypothalamic hormones on GH secretion. Although multiple second messengers have been implicated, the adenylate cyclase-cyclic AMP-protein kinase A system appears to exert a predominant role. The developmental regulation of the somatotropes and of GH gene expression is also of importance in determining the GH responses to releasing and inhibiting hormones. The availability of several rodent strains with genetic disorders of growth associated with impaired GH secretion, along with the development of transgenic models, has permitted a more detailed analysis of the role of cytokines and growth factors on both somatotrope biology and hormone secretion. Finally, knowledge gained from studies in animals is permitting a better understanding of the mechanisms involved in physiologic GH secretion and altered GH secretion associated with specific disease states in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360911

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  14 in total

1.  Peptides derived from pro-growth hormone-releasing hormone activate p38 mitogen-activated protein kinase in GH3 pituitary cells.

Authors:  R Steinmetz; P Zeng; D W King; E Walvoord; O H Pescovitz
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 2.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Overexpression of growth hormone affects alternatively spliced IGF-I mRNA expression in oMt1a-oGH transgenic mice.

Authors:  W W Lin; J D Murray; A M Oberbauer
Journal:  Transgenic Res       Date:  1998-07       Impact factor: 2.788

4.  Oral arginine improves linear growth of long bones and the neuroendocrine mechanism.

Authors:  Ming-Yu Jiang; De-Pei Cai
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

Review 5.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

6.  Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.

Authors:  K Thapar; K Kovacs; L Stefaneanu; B Scheithauer; D W Killinger; R V Lioyd; H S Smyth; A Barr; M O Thorner; B Gaylinn; E R Laws
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  The effects of gonadal development and sex steroids on growth hormone secretion in the male tilapia hybrid (Oreochromis niloticus × O. aureus).

Authors:  P Melamed; N Eliahu; M Ofir; B Levavi-Sivan; J Smal; F Rentier-Delrue; Z Yaron
Journal:  Fish Physiol Biochem       Date:  1995-08       Impact factor: 2.794

8.  Growth hormone-releasing hormone stimulates cAMP release in superfused rat pituitary cells.

Authors:  J E Horváth; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.

Authors:  Emmanuel Somm; Nicolas Bonnet; Alberto Martinez; Philip M H Marks; Verity A Cadd; Mark Elliott; Audrey Toulotte; Serge L Ferrari; René Rizzoli; Petra S Hüppi; Elaine Harper; Shlomo Melmed; Richard Jones; Michel L Aubert
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

10.  Up-regulation of high voltage-activated Ca(2+) channels in GC somatotropes after long-term exposure to ghrelin and growth hormone releasing peptide-6.

Authors:  Belisario Dominguez; Traudy Avila; Jorge Flores-Hernandez; Gustavo Lopez-Lopez; Herminia Martinez-Rodriguez; Ricardo Felix; Eduardo Monjaraz
Journal:  Cell Mol Neurobiol       Date:  2008-02-08       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.